BIOMAT Database Logo BIOMAT Database Logo

Immunoreactive corticotropin-releasing hormone, adrenocorticotropin and cortisol in human plasma during pregnancy and delivery and postpartum. 1989

E Okamoto, and T Takagi, and T Makino, and H Sata, and I Iwata, and E Nishino, and N Mitsuda, and N Sugita, and Y Otsuki, and O Tanizawa
Department of Obstetrics and Gynecology, Osaka University Medical School, Japan.

The activity of the hypothalamo-pituitary adrenal axis was examined, by measuring the levels of immunoreactive (IR) corticotropin-releasing hormone (CRH), adrenocorticotropin (ACTH) and cortisol (F) in human plasma during normal pregnancy and after delivery with or without complications and during normal postpartum using a specific RIA. The level of IR-CRH in maternal plasma increased progressively during pregnancy, increased further at delivery and declined rapidly to the non-pregnant level on the 1st day postpartum. The level of IR-F in maternal plasma also increased progressively during pregnancy, increased further at delivery, but decreased slowly postpartum, not returning to the non-pregnant level within 5 days. Significant correlations were found between the level of IR-CRH and IR-ACTH, IR-CRH and IR-F, and IR-ACTH and IRF in maternal plasma both during pregnancy and after delivery. It is noteworthy that the concentration of IR-CRH in the maternal plasma at delivery was higher in multiple pregnancy than in normal pregnancy, and that the level of IR-CRH in the umbilical cord in uncomplicated cases was much lower than that in the maternal plasma, and was significantly lower than those in the umbilical cord plasma in cases of asphyxia, IUGR or premature delivery. The level of IR-F, not IR-CRH and IR-ACTH, at normal vaginal delivery was significantly higher than that at elective cesarean section. On these results, we investigated the feto-maternal-hypothalamo-pituitary adrenal axis during pregnancy and delivery, in which CRH plays an important role.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D007743 Labor, Obstetric The repetitive uterine contraction during childbirth which is associated with the progressive dilation of the uterine cervix (CERVIX UTERI). Successful labor results in the expulsion of the FETUS and PLACENTA. Obstetric labor can be spontaneous or induced (LABOR, INDUCED). Obstetric Labor
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D003346 Corticotropin-Releasing Hormone A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS. ACTH-Releasing Hormone,CRF-41,Corticotropin-Releasing Factor,Corticotropin-Releasing Hormone-41,ACTH-Releasing Factor,CRF (ACTH),Corticoliberin,Corticotropin-Releasing Factor-41,ACTH Releasing Factor,ACTH Releasing Hormone,Corticotropin Releasing Factor,Corticotropin Releasing Factor 41,Corticotropin Releasing Hormone,Corticotropin Releasing Hormone 41
D005260 Female Females
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Okamoto, and T Takagi, and T Makino, and H Sata, and I Iwata, and E Nishino, and N Mitsuda, and N Sugita, and Y Otsuki, and O Tanizawa
Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery.
February 1987, The Journal of clinical endocrinology and metabolism,
E Okamoto, and T Takagi, and T Makino, and H Sata, and I Iwata, and E Nishino, and N Mitsuda, and N Sugita, and Y Otsuki, and O Tanizawa
Plasma corticotropin-releasing hormone, beta-endorphin and cortisol inter-relationships during human pregnancy.
April 1993, Acta endocrinologica,
E Okamoto, and T Takagi, and T Makino, and H Sata, and I Iwata, and E Nishino, and N Mitsuda, and N Sugita, and Y Otsuki, and O Tanizawa
Effect of ovine corticotropin-releasing hormone administered during insulin-induced hypoglycemia on plasma adrenocorticotropin and cortisol.
June 1987, The Journal of clinical endocrinology and metabolism,
E Okamoto, and T Takagi, and T Makino, and H Sata, and I Iwata, and E Nishino, and N Mitsuda, and N Sugita, and Y Otsuki, and O Tanizawa
The corticotropin-releasing hormone test in normal short children: comparison of plasma adrenocorticotropin and cortisol responses to human corticotropin-releasing hormone and insulin-induced hypoglycemia.
March 1989, Acta endocrinologica,
E Okamoto, and T Takagi, and T Makino, and H Sata, and I Iwata, and E Nishino, and N Mitsuda, and N Sugita, and Y Otsuki, and O Tanizawa
Human corticotropin-releasing hormone during pregnancy.
January 1989, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
E Okamoto, and T Takagi, and T Makino, and H Sata, and I Iwata, and E Nishino, and N Mitsuda, and N Sugita, and Y Otsuki, and O Tanizawa
The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients.
February 1986, The Journal of clinical endocrinology and metabolism,
E Okamoto, and T Takagi, and T Makino, and H Sata, and I Iwata, and E Nishino, and N Mitsuda, and N Sugita, and Y Otsuki, and O Tanizawa
Ethnic differences in adrenocorticotropic hormone, cortisol and corticotropin-releasing hormone during pregnancy.
June 2007, Peptides,
E Okamoto, and T Takagi, and T Makino, and H Sata, and I Iwata, and E Nishino, and N Mitsuda, and N Sugita, and Y Otsuki, and O Tanizawa
Mifepristone: effect on plasma corticotropin-releasing hormone, adrenocorticotropic hormone, and cortisol in term pregnancy.
July 2004, Journal of perinatology : official journal of the California Perinatal Association,
E Okamoto, and T Takagi, and T Makino, and H Sata, and I Iwata, and E Nishino, and N Mitsuda, and N Sugita, and Y Otsuki, and O Tanizawa
Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men.
April 1986, The Journal of clinical endocrinology and metabolism,
E Okamoto, and T Takagi, and T Makino, and H Sata, and I Iwata, and E Nishino, and N Mitsuda, and N Sugita, and Y Otsuki, and O Tanizawa
Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone.
August 1985, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!